- Book
- April 2020
- 336 Pages
- Book
- April 2019
- 816 Pages
- Book
- July 2018
- 832 Pages
- Book
- January 2017
- 504 Pages
- Book
- September 2016
- 680 Pages
- Book
- May 2016
- 288 Pages
- Book
- March 2015
- 352 Pages
- Book
- October 2013
- 624 Pages
- Book
- October 2012
- 456 Pages
- Book
- August 2012
- 112 Pages
- Book
- April 2012
- 1272 Pages
- Book
- February 2012
- 496 Pages
- Book
- September 2010
- 424 Pages
- Book
- May 2009
- 354 Pages
- Book
- February 2020
- 1152 Pages
The Liver Transplantation market within the context of Biotechnology is a rapidly growing field of medical research and development. It involves the transplantation of a healthy liver from a donor into a patient with a diseased or damaged liver. This procedure is used to treat a variety of liver diseases, including cirrhosis, hepatitis, and liver cancer. The transplantation process involves the removal of the diseased liver and the replacement of it with a healthy donor liver. The donor liver is then connected to the patient's blood vessels and bile ducts, allowing the patient to receive the donor liver's healthy cells and nutrients.
The Liver Transplantation market is driven by advances in medical technology, such as the development of new surgical techniques and the use of immunosuppressant drugs to reduce the risk of organ rejection. Additionally, the increasing prevalence of liver diseases and the growing demand for organ transplants are contributing to the growth of the market.
Some of the major companies in the Liver Transplantation market include Astellas Pharma, Novartis, Roche, and Johnson & Johnson. Show Less Read more